Neue Suche | Kongressdetail
mail
Druckansicht
 
 

TCR-based Therapies for Solid Tumors Summit

Evvnt Promotion / evvnt
-
03.04.2023 - 05.04.2023  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 09:00 to 16:30
 
Kongressthemen
The first TCR-based therapy approval in the US and Europe at the start of this year sparked a rush of excitement, investment and collaborations. As further developers move into the clinic and some near commercialization, it's time for this community to unite to address the critical bottlenecks faced in development, from discovery to approval, to guarantee smooth sailing through the clinic.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/1444012-3?pid=4832

Speakers: Birgit Schultes, Senior Vice President, Cell Therapy, Intellia Therapeutics, Claudia Wagner, Senior Director, Immunology, Head of TCR Discovery and Validation, Immatics, and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/1444012-2?pid=4832
Frau Ellie Saunders
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2599.00 - USD 5997.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

European Health Forum GasteinÄrzte der WeltSwiss Tropical and Public Health InstituteHilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Public Health Association (EUPHA)Alumni Club Medizinische Universität WienCenter of Excellence